Audio
View More
American Gastroenterological Association (AGA)
4930 Del Ray Avenue
Bethesda, MD 20814
Phone: (301) 654-2055
Fax: (301) 654-5920
Email: member@gastro.org
Stephen A. Harrison, MD, COL (Ret.), FAASLD, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 29, 2019
Kenneth Cusi, MD, FACP, FACE, explains how to interpret endpoints used in NASH studies so you can evaluate emerging treatments.
Kenneth Cusi, MD, FACP, FACE
Kenneth Cusi, MD, FACP, FACE, and Stephen A. Harrison, MD, COL (Ret.), FAASLD, explain how to interpret endpoints used in NASH studies so you can evaluate emerging treatments
Kenneth Cusi, MD, FACP, FACE
Stephen A. Harrison, MD, COL (Ret.), FAASLD
Released: March 26, 2019
Raymond E. Soccio, MD, PhD, summarizes the roles of weight loss and diabetes drugs in NASH
Raymond E. Soccio, MD, PhD
Released: March 7, 2019
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.